Vaccines

President Joe R. Biden marked the anniversary of the onset of the COVID-19 coronavirus pandemic with a flood of action.

The new doses will spring from the production partnership of Johnson & Johnson and Merck.

Those who have been fully vaccinated can safely visit other vaccinated people and small groups of those who have yet to get the jab.

The next MJH Life Sciences COVID-19 Coalition webinar will focus on building confidence in vaccines.

Multiple news organizations report that the White House has brokered the unusual deal.

The next MJH Life Sciences COVID-19 Coalition webinar will focus on building confidence in vaccines.

The single-dose vaccine is the third granted emergency use authorization in an effort to end the COVID-19 coronavirus pandemic.

Documents released by the FDA before they consider an EUA for the single-dose vaccine show that it is effective against COVID-19.

The drug maker expects to deliver 120 million doses of its COVID-19 vaccine by the end of March.

The MJH Life Sciences COVID-19 Coalition will discuss the legal and ethical considerations of COVID-19 vaccinations in a free webinar tomorrow at 6 p.m. EST.

More than half of Americans expect disruptions to persist past the middle of this year, a jump from late-December’s responses.

The MJH Life Sciences COVID-19 Coalition will discuss the legal and ethical considerations of COVID-19 vaccinations in a free webinar at 6 p.m. EST, Feb. 24.

In a pair of letters to congressional committees, the organization extolls the benefits of provisions in upcoming COVID relief legislation.

Primary care physicians are getting involved with the vaccination effort, but only 19 percent say they’re currently administering the shots.

The public service announcement urges Americans to be vaccinated against COVID-19.

The drug maker has started reviews with regulatory agencies across the world.

The company plans to supply the federal government with 100 million doses in the first half of 2021.

Anders Gilberg, senior vice president of government affairs for MGMA, discusses a recent survey and how his organization is reaching out to the White House.

With the holidays upon us, concern continue to increase about the combination of influenza and COVID-19.

New COVID-19 coronavirus vaccine candidates from Johnson & Johnson and Novavax have shown high efficacy on some variants of the disease.

A survey found more Americans looking to get vaccinated as soon as possible versus in December.

The drug maker says their vaccine is still effective against emerging COVID-19 variants, but it still wants to test.

The survey showed that a vast majority of independent practices actively seeking COVID-19 vaccines haven’t received any doses.

The AAFP president says family physicians are uniquely positioned to educate patients, prioritize access, and coordinate administration of COVID-19 coronavirus vaccines.

Let us know how the vaccine rollout is going.

The nearly $20 million in CARES Act funds will be used to expand information sharing between health information exchanges and immunization information systems.

The organization says that cutting primary care practices out of the vaccination process would jeopardize the success of the enterprise.

The organization says it is supportive and encouraged by the incoming administrations plans to address the COVID-19 coronavirus pandemic.

In a statement, ACP President Jacqueline W. Fincher, MD, MACP, says vaccine prioritization should be based on medical need.